Alder Therapeutics

At Alder Therapeutics, we are on a bold mission to cure the incurable by bringing pluripotent stem cell-developed therapies to the benefit of patients. We are developing two promising allogeneic stem cell therapies, both with pre-clinical proof of concept data. Our lead program is a retinal cell therapy to treat Retinitis Pigmentosa, with a second program to tackle heart failure. Our industry-renowned team has decades of expertise in the scientific, technical and commercial aspects of bringing game-changing allogeneic cell therapies to market. Our focus is on de-risking cell therapy development by keeping the commercial product in mind from the start.